register free | resend password

Pressemitteilungen zu dem Thema bios


Unterkategorien

PresseMitteilungen zu dem Schlagwort bios


Biostimulants Market: A Straight Overview of Growth Factors and Future Prospects 2016 – 2023

The latest market report published by Credence Research, Inc. Market Insights: There has been an upsurge in the demand for organic food products across the globe. This is fuelling the demand for efficient crops, furthermore to meet the demand for food in the growing world population. Agriculture is a key indicator having an impact on a particular country Browse the full Biostimulants Market - Growth, Future Prospects and Competitive Analysis, 2016 Since, these countries are among top 25 countr ...


03.01.2018

Cell Culture Monitoring Biosensors Market is predicted to exhibit a CAGR of over 9.6 % from 2017 to 2025, Credence Research

The latest market report published by Credence Research, Inc. Market Insights The drugs market in recent years is more inclined towards developing molecules focused on target based therapies such as biologics, personalized medicines and biosimilars. Target based therapies are predominantly required for treating chronic diseases and orphan conditions, hence the development of the suitable medication should be expedited. The successful example of personalized medicine is approval of the product k ...


06.12.2017

Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/14/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments and related consumables to the worldwide life sciences industry, today announced financial results for the third quarter of 2017, provided a business update, and offered limited guidance on its expected revenue for remainder of FY 2017.Mr. Joseph L. Damasio, Jr., VP of Finance ...


14.11.2017

Biosimulation Market Regulations, Size, Share and Competitive Landscape Outlook to 2025: Credence Research

The latest market report published by Credence Research, Inc. “Biosimulation Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” the biosimulation market was valued at US$ 1.18 Bn in 2016, and is expected to reach US$ 4.12 Bn by 2025, expanding at a CAGR of 14.8 % from 2017 to 2025. Market Insights The biosimulation market is expected to show remunerative growth in the forecast period of 2017-2025. Biosimulation also known as ‘modeling and simulation’, or ‘model-based drug de ...


14.11.2017

Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/13/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company''s website).The teleconferenc ...


13.11.2017

Biostimulants Market to Register Substantial Expansion and Growth by 2023- Credence Research

The latest market report published by Credence Research, Inc. “Biostimulants Market, By Crop Type, Application and Active Ingredients - Growth, Future Prospects and Competitive Analysis, 2016 - 2023,” the global biostimulants market was valued at US$ 1.7 Bn in 2015, and is expected to each US$ 3.8 Bn by 2023, expanding at a CAGR of 10.7% from 2016 to 2023. Market Insights: There has been an upsurge in the demand for organic food products across the globe. This is fuelling the demand for efficien ...


10.11.2017

Nemus Bioscience Files Arbitration Petition Against Schneider Finance, LLC and SB Securities, Ltd. for Failure to Close $20 Million Financing and Failure to Honor Guarantee

COSTA MESA, CA -- (Marketwired) -- 11/09/17 -- (OTCQB: NMUS) (the "Company") today announced that it has submitted a demand commencing arbitration against Schneider Finance, LLC and SB Securities, Ltd., both affiliates of Schneider Brothers Ltd., as well as other individuals. SB Securities, Ltd. also uses the name "Schneider Securities." In the petition, the Company asserts, among other things, breach of contract against Schneider Finance, LLC for its failure to close its p ...


09.11.2017

Corix Bioscience Purchases Pharmaceutical Development Corp LTD

PHOENIX, AZ -- (Marketwired) -- 11/07/17 -- Corix Bioscience Inc. (OTCQB: CXBS) has purchased 100% of Pharmaceutical Development Corp., allowing Corix to commence selling its proprietary cannabis products internationally.Michael Ogburn, Corix Bioscience CEO, stated, "This is a defining moment for our company. It allows us to grow and manufacture cannabis in Lesotho and distribute our products to dozens of other countries. It will allow us to accelerate our growth very quickly. This deal wi ...


07.11.2017

NEMUS Bioscience Announces Presentation of CBD-analogue Therapeutic Data Related to Neuropathic Pain (NB2111) and Ocular Diseases (NB2222) at Upcoming Scientific Meetings

COSTA MESA, CA -- (Marketwired) -- 11/06/17 -- (OTCQB: NMUS) announced that data obtained from the company''s research and development partner, the University of Mississippi (UM), will be presented at upcoming scientific meetings in November.Research under the direction of Dr. Kenneth Sufka (University of Mississippi) utilizing cannabinoid research led by Dr. Mahmoud ElSohly (University of Mississippi and ElSohly Laboratories, Inc.) will be presented on November 12, 2017 during the a ...


06.11.2017

Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China

SOUTH EASTON, MA -- (Marketwired) -- 11/01/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, today announced that Professor Tiannan Guo''s laboratory at Westlake Institute for Advanced Study ("WIAS") has been named the Company''s first Center of Excellence (&quo ...


01.11.2017

Microbix Completes Second Tranche of Brokered Private Placement

TORONTO, ONTARIO -- (Marketwired) -- 10/27/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017. An aggregate of 7,784,500 Units were issued in the first tranche for gross proceeds of $2.33 million. Microbix has now closed a second tranche of private placemen ...


27.10.2017

BIOS update enables Kaby Lake support

Industrial mainboards and CPU cards are usually used for five to ten years. Consequently, the boards have to work reliably over a long period of time. However, if the performance requirements increase or the applications become more complex, a complete hardware exchange is necessary. ICP Deutschland offers its customers a cost-effective and simple alternative. Via a BIOS update of certain Skylake CPU boards and cards, the support of Kaby Lake processors is realized. So there is no need of replac ...


24.10.2017

Microbix Completes Brokered Private Placement

TORONTO, ONTARIO -- (Marketwired) -- 10/19/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in the issue of 7,784,500 million units ("Units") at a price of $0.30 per unit.Each Unit consists of one common share ("Common Share") of Microbix and one-half of ...


19.10.2017

Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

SOUTH EASTON, MA -- (Marketwired) -- 10/18/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, today announced a collaboration with Phasex Corporation, one the world''s most experienced supercritical fluid ("SCF")-based toll processors. Since 1981, Phasex has been a leader in the development of cutt ...


18.10.2017

NEMUS Bioscience Provides Further Update on Previously Announced $20 Million Schneider Financing

COSTA MESA, CA -- (Marketwired) -- 10/13/17 -- (OTCQB: NMUS) (the "Company") today announced a further update to its news releases dated May 4, 2017 and July 11, 2017 with respect to the signing of a private placement with Schneider Finance LLC, an affiliate of Schneider Brothers Ltd, a global closed investment fund, for the sale of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000. As previously announced, SB Securities Ltd, an affiliate of ...


13.10.2017

Microbix Announces End of Legal Dispute

TORONTO, ONTARIO -- (Marketwired) -- 10/11/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announce the withdrawal of legal claims alleging patent infringement that were filed in Canadian Federal Court against Microbix by ZeptoMetrix Corporation in October, 2016.The allegations by ZeptoMetrix have been withdrawn, following a settlement reached by the two companies. The withdrawal of the lawsuit is "with prejudice," meanin ...


11.10.2017

Corix Bioscience Inc. to Purchase 46,060 Square Foot Research Facility

PHOENIX, AZ -- (Marketwired) -- 10/05/17 -- Corix Bioscience Inc. (OTCQB: CXBS) has entered into a contract to purchase a 46,060 square foot building in Carson City, Nevada. Closing is expected to occur on or before November 4, 2017. Purchase price for the building was finalized at $1,300,000.The building will serve as Corix Bioscience''s new research and development laboratory with an indoor grow facility specifically for their industrial hemp genetics. Genetics of industrial hemp an ...


05.10.2017

Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum

NEW YORK, NY -- (Marketwired) -- 09/29/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces today that it has launched TSW Topicals (), a range of over-the-counter, topical pain relief products using an innovative blend of clinically proven organic ingredients such as menthol, curcumin, ginger and capsaicin to reduce inflammation and e ...


29.09.2017

Pressure BioSciences'' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

SOUTH EASTON, MA -- (Marketwired) -- 09/18/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company''s next-generation PCT instrument -- the Barocycler 2320EXTREME (the "Barocycler 2320EXT") -- has been selected as a Finalist in ...


18.09.2017

Microbix Announces First Shipment of Bioreactor Antigen

TORONTO, ONTARIO -- (Marketwired) -- 09/13/17 -- Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation.Microbix'' revenues are derived principally from the sales of its antigens for use in diagnostic tests. Historically, those antigens have been produced in thousands of "roller bottles," a ...


13.09.2017

Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017

SOUTH EASTON, MA -- (Marketwired) -- 09/11/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 19th Annual Rodman & Renshaw Global Investment Conference.Mr. Schumach ...


11.09.2017

Corix Enters California Cannabis Market Adding 3 Licenses

PHOENIX, AZ -- (Marketwired) -- 09/07/17 -- Corix Bioscience Inc. (OTCQB: CXBS) formally announces that it is acquiring 3 California cannabis licenses from California-based brand, E&B Investments LLC, for $2,000,000, consisting of $250,000 cash and the balance in restricted common stock. A deposit was given on August 29, 2017 with the closing date scheduled for September 8, 2017.The licenses consist of: (1) Type 3A (large indoor cultivation), (1) Type 6/7 (manufacturing products using volat ...


07.09.2017

Amarillo Biosciences, Inc. Announces Investor Update

AMARILLO, TX -- (Marketwired) -- 09/06/17 -- Amarillo Biosciences, Inc. (ABI) (OTC PINK: AMAR) has identified certain goals for its future business development, and wishes to share this information with both its shareholders and the general public. ABI recognizes that it needs to create new products and get them to market, monetize and commercialize its intellectual property, leverage core technology, and develop research capabilities to become an integrated healthcare enterprise of global dist ...


06.09.2017

Clasado Biosciences Brings Its Revolutionary Prebiotic Supplement to SupplySide West

JERSEY, CHANNEL ISLANDS -- (Marketwired) -- 08/25/17 -- , the international biotechnology company and global leader in the research of gut mediated wellness solutions, today announced that it will be showcasing Bimuno, its patented pioneering food supplement, at SupplySide West. The annual event is the industry''s gathering point where the science and strategy of food development combine to help identify the products that will grow the global functional food economy.SupplySide West 20 ...


25.08.2017

Microbix to Amend Share Purchase Warrant Terms

TORONTO, ONTARIO -- (Marketwired) -- 08/24/17 -- Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the "Warrants") issued in connection with a non-brokered private placement and held by one of its independent directors.The Warrants were issued in relation to a non-brokered private placement of units comprised of one common share and ...


24.08.2017

Pressure BioSciences, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/16/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced financial results for the second quarter of 2017, provided a business update, and offered limited guidance on its growth plan for FY2017.Total revenue for the 2017 sec ...


16.08.2017

Corix Bioscience, Inc. Signs Major Sales Agreement for up to 22,000 Pounds of Hemp per Month

PHOENIX, AZ -- (Marketwired) -- 08/16/17 -- Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade cannabinoid oil (CBD) manufacturer, announced today that it has signed an agreement with Positively Green Organics LLC. for the resale of up to 22,000 pounds of industrial hemp per month.Positively Green Organics LLC. (PGO) grows industrial hemp on a 160-acre plot of land just south of Carson City, Nevada for the production of CBD oil, the main medicinal ...


16.08.2017

Pressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/15/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company''s website).The teleconferen ...


15.08.2017

Akers Biosciences Announces Q2 2017 Earnings

THOROFARE, NJ -- (Marketwired) -- 08/15/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, reports its financial results for the three months and six months ended June 30, 2017. The Form 10-Q containing the full financial statements for the three months and six months ended June 30, 2017 is available for viewing on the Company''s website at or at .Total revenues up 25% fo ...


15.08.2017

Microbix Reports Record Third Quarter & Nine Month Sales

TORONTO, ONTARIO -- (Marketwired) -- 08/14/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 ("Q3" and "9 Mo.").Third Quarter Financial ResultsTotal Q3 revenue was $2,773,365, an increase of 23% compared to the same quarter of fiscal 2016. Most revenues were derived from sales of antigen products, which are principally used in the m ...


14.08.2017

Corix Bioscience Announces New Tissue Culture and Research Lab

PHOENIX, AZ -- (Marketwired) -- 08/11/17 -- Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade cannabinoid oil (CBD) manufacturer, announces that they will move their tissue cell culture and research divisions into a new 10,122 square foot laboratory in Carson City, Nevada on a three-year lease. The lease commenced on August 1st.This move will enable Corix to produce over 3 million plantlets in the immediate future and set them up to double that i ...


11.08.2017

Microbix Announces Expanded Customer Supply Agreement

TORONTO, ONTARIO -- (Marketwired) -- 08/08/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix'' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are expected to total $25 million, with approximately $10 million being new business.Microbix i ...


08.08.2017

Akers Biosciences Announces Board Changes

THOROFARE, NJ -- (Marketwired) -- 08/08/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces a series of new board appointments to the Company''s board of directors (the "Board").At the Company''s annual shareholder meeting held yesterday in Philadelphia, PA, shareholders elected three new non-executive directors to the Board, , and ; together ...


08.08.2017

NEMUS Bioscience Announces Presentation of CBD-analogue (NB2222) Ocular Data at the AAPS 2017 Annual Meeting

COSTA MESA, CA -- (Marketwired) -- 08/07/17 -- (OTCQB: NMUS) announced that data recently obtained from the company''s research and development partner, the University of Mississippi (UM), will be presented at the American Association of Pharmaceutical Scientists (AAPS) meeting to be held in San Diego, CA on November 12-15, 2017. The data will be presented by Dr. Soumyajit Majumdar, Professor of Pharmaceutics and Drug Delivery and Associate Dean for Research and Graduate Programs in ...


07.08.2017

Corix Bioscience Announces Ticker Symbol Change to CXBS

PHOENIX, AZ -- (Marketwired) -- 08/02/17 -- Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade oil manufacturer, today officially announced that, effective August 2, 2017, the company will commence trading on the OTCQB under the new trading symbol "CXBS." The change reflects the company''s focus as a next generation developer of proprietary Cannabis and Hemp strains using tissue cell cultures in our laboratory and grows these p ...


02.08.2017

Rising Biosciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications

NEW YORK, NY -- (Marketwired) -- 08/02/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces that the Company has entered in the FDA testing phase on its revolutionary medical creams for chronic pain relief and neuropathic pain.These two pain creams will be the first in a series of products. Rising Biosciences, Inc. has retained an indu ...


02.08.2017

Nemus Bioscience Announces Presentation of NB2111 Analgesic and Anti-Addiction Data at NIH-Sponsored Cannabinoid Conference

COSTA MESA, CA -- (Marketwired) -- 08/02/17 -- (OTCQB: NMUS) announced that data recently obtained from the company''s research and development partner, the University of Mississippi (UM), will be presented on August 12th at the Chemistry and Pharmacology of Drug Abuse Conference supported by the National Institute of Drug Abuse (NIDA) meeting held at Northeastern University in Boston, MA. NIDA is one of the twenty-seven institutes that constitute the National Institutes of Health (N ...


02.08.2017

Evolve BioSystems, Inc. announces Timothy B. Brown as new CEO, David Kyle named Executive Chairman and Chief Scientific Officer

DAVIS, CA -- (Marketwired) -- 08/01/17 -- The Board of Directors of Evolve BioSystems, Inc. has appointed Timothy B. Brown as CEO effective August 1, 2017. Mr. Brown will also join the Company''s Board of Directors effective that same date. Dr. David J. Kyle, the Company''s current CEO, will assume the new role of Executive Chairman of the Board of Directors of the Company and remain active as Evolve''s Chief Scientific Officer.Mr. Brown has served as Evolve BioSys ...


01.08.2017

Microbix Announces Leadership Transition

TORONTO, ONTARIO -- (Marketwired) -- 07/24/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has appointed Mr. Cameron Groome as its President and CEO, with Mr. Vaughn Embro-Pantalony retiring from those positions but remaining an executive director working closely with Mr. Groome to ensure a smooth leadership transition.Cameron Groome has been in the life sciences indu ...


24.07.2017

NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

COSTA MESA, CA -- (Marketwired) -- 07/17/17 -- (OTCQB: NMUS) announced that data recently obtained from the company''s research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data being presented will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated m ...


17.07.2017

NEMUS Bioscience Provides Update on Previously Announced $20 Million Schneider Financing

COSTA MESA, CA -- (Marketwired) -- 07/11/17 -- (OTCQB: NMUS) (the "Company") today announced an update to its news release dated May 4, 2017 with respect to the signing of a private placement with Schneider Finance LLC, an affiliate of Schneider Brothers Ltd, a global closed investment fund with over USD $500 million in assets, for the sale of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000. The securities purchase agreement provides for ...


11.07.2017

Nemus Bioscience Announces NB1111 Data Presentation at the 27th Annual Symposium of the International Cannabinoid Research Society (ICRS)

COSTA MESA, CA -- (Marketwired) -- 06/22/17 -- (OTCQB: NMUS) announced that tetrahydrocannabinol (THC) derived from NB1111, the proprietary Nemus prodrug of THC, achieved significant tissue concentrations in multiple compartments of the eye that correlated with the lowering of IOP in a normotensive ocular animal model. The data will be presented on Saturday, June 24th at 1pm EDT at the 2017 ICRS Meeting in Montreal, Canada by the company''s research and discovery partner, the Univers ...


22.06.2017

Clasado Biosciences to Exhibit at IFT17 Food Expo(R) in Las Vegas

JERSEY, CHANNEL ISLANDS -- (Marketwired) -- 06/21/17 -- today announced it will exhibit at IFT17: Go With Purpose, the preeminent annual event focused on the science of food and food technology hosted by the Institute of Food Technologists (IFT). IFT17 takes place June 25-28, 2017, in Las Vegas, Nevada, and will bring together over 20,000 food professionals, academics, and researchers from more than 90 countries to collaborate, share, and learn about innovations in the science of food and food ...


21.06.2017

BioStem Technologies, Inc. Announces Letter of Intent with Watermakers, Inc. to begin testing on Staniel Cay in the Exuma Cays, Bahamas

POMPANO BEACH, FL -- (Marketwired) -- 06/09/17 -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BSEM" or "the company"), a global corporation providing world-class solutions focused on Regenerative Medicines, Pharmaceuticals and Blue Technologies, is eager to announce that its Oakland Park, Florida based subsidiary, BioBlue Technologies Inc. ("BioBlue"), has signed a Letter of Intent ("LOI") with Watermakers, Inc. for industrial water treatment.Staniel Ca ...


09.06.2017

WSI Industries Announces Earnings Release Date

MINNEAPOLIS, MN -- (Marketwired) -- 06/07/17 -- WSI Industries, Inc. (NASDAQ: WSCI) today announced that it expects to release its fiscal 2017 third quarter financial results on June 22, 2017 after market close.WSI Industries, Inc. is a leading contract manufacturer that specializes in the machining of complex, high-precision parts for a wide range of industries, including automotive, avionics and aerospace, energy, recreational powersports vehicles, small engines, bioscience and the defense ma ...


07.06.2017

Pressure BioSciences'' Barocycler 2320EXTREME to be Featured in Multiple Presentations All Week at Major Scientific Meeting

SOUTH EASTON, MA -- (Marketwired) -- 06/06/17 -- Pressure BioSciences, Inc. (OTCQB: PBIOD) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company''s patented PCT platform will be featured in multiple presentations at the annual conference of the American Society for Mass Spectrometry ...


06.06.2017

Dr. Ruedi Aebersold Receives the Prestigious Karger Medal Recognizing an Individual Who Has Significantly Contributed to the Development of New Bioanalytical Methods

SOUTH EASTON, MA -- (Marketwired) -- 06/05/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Dr. Ruedi Aebersold recently received the prestigious Karger Medal from the Barnett Institute of Chemical & Biological Analysis at Northeastern University in ...


05.06.2017

Corix Bioscience Announces Contract with Segra International, Inc.

PHOENIX, AZ -- (Marketwired) -- 06/05/17 -- Corix Bioscience Inc. (OTCQB: AHIT) is pleased to announce that it has contracted Segra International Inc. to plan and construct a state of the art tissue culture facility in Northern Nevada.Corix Bioscience Inc. is a fully integrated grower and manufacture of cannabinoids with an emphasis on CBD and THCV oil. Corix currently has over 200 acres of industrial hemp contracted that will sold as both dry flower and refined into CBD oil this fall.Currently ...


05.06.2017

Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split

SOUTH EASTON, MA -- (Marketwired) -- 06/02/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company''s outstanding convertible securities will also be adjusted accordingly.The reverse stock split is intended to increase the per share trading price of the Company''s common stock to satisfy the $4.00 minim ...


02.06.2017

Evolve BioSystems Completes $20 Million Series B Financing

DAVIS, CA -- (Marketwired) -- 05/30/17 -- Evolve BioSystems, Inc., a microbiome company committed to developing novel solutions to restore and maintain a healthy newborn gut microbiome, today announced that it has completed a $20 million Series B financing to fund the commercialization of its initial products. Spruce Capital Partners/MLS led the investment round with participation from existing shareholders, including Horizons Ventures and Tate & Lyle Ventures. New investors Bow Capital and ...


30.05.2017

Clinical Trial Evaluating the Effect of Prolact CR(R) on Length of Stay and Bronchopulmonary Dysplasia Among Very Low Birth Weight Infants Surpasses the Halfway Point

DUARTE, CA -- (Marketwired) -- 05/25/17 -- ®, the pioneer in human milk-based neonatal nutritional products for premature infants, announced today that it passed the halfway point in a clinical trial evaluating the effect of adding , a caloric fortifier made from 100 percent human milk cream, to an exclusive human milk-based diet (EHMD)(1) for very low birth weight (VLBW) premature infants. The study is evaluating the length of stay and incidence of bronchopulmonary dysplasia (BPD) and has enro ...


25.05.2017

BioSyent Releases Q1 2017 Results

TORONTO, ONTARIO -- (Marketwired) -- 05/25/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) released today a summary of its financial results for the three months ended March 31, 2017. Key highlights include:"Q1 2017 marked BioSyent''s 27th consecutive profitable quarter" remarked Rene Goehrum, President and CEO of BioSyent. "While we maintained a healthy net profit margin, Q1 2017 growth was somewhat constrained, in part, by the lower inventory carrying le ...


25.05.2017

REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India

BELTSVILLE, MD and PHILADELPHIA, PA -- (Marketwired) -- 05/23/17 -- REPROCELL and Fox Chase Cancer Center today announced a joint venture to open a multi-site biosample repository facility in India. Initial operations are underway in Delhi with plans to expand to Hyderabad in the fourth quarter."The research community''s demand for access to clinical-grade bio-specimens from India has gone largely unmet. Through our partnership with Fox Chase, we plan to change that," said R ...


23.05.2017

Pressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 05/16/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced financial results for the first quarter of 2017, provided a business update, and offered limited guidance on its growth plan for FY2017.Products and services revenue i ...


16.05.2017

Nemus Bioscience Reports Prodrug of Tetrahydrocannabinol (THC) Receives Second Patent Issued in the United States Related to Proprietary Delivery Mechanisms for Treatment of Glaucoma

COSTA MESA, CA -- (Marketwired) -- 05/09/17 -- (OTCQB: NMUS) announced that an additional United States patent has been granted covering the company''s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as other amide-ester forms of cannabinoid-based molecules, for use in the treatment of glaucoma. This second patent, which is also licensed to Nemus by the University of Mississippi, further expands the intellectual property (IP) estate into methods of delivery of ...


09.05.2017

Prolacta Bioscience(R) Launches Nursing Practice Advisory Council and Salutes Neonatal Nurses and Nurse Practitioners During National Nurse Week

DUARTE, CA -- (Marketwired) -- 05/08/17 -- , the nation''s leading provider of human milk-based neonatal nutritional products to hospitals, recognizes and honors the clinical expertise, dedication and commitment to care of neonatal nurses during National Nurse Week (May 6-12, 2017) with its support of four nursing conferences and the launch of a national Nursing Practice Advisory Council (NPAC).The NPAC is an advisory group composed of neonatal nursing leaders who are passionate about ...


08.05.2017

Nemus Bioscience Announces $20 Million Series E Preferred Stock Financing

COSTA MESA, CA -- (Marketwired) -- 05/04/17 -- NEMUS Bioscience, Inc. (OTCQB: NMUS) (the "Company") today announced the signing of a private placement with an affiliate of Schneider Brothers Ltd, a global closed investment fund with over USD$500 million in assets, for the sale of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000. Each share of preferred stock is convertible into shares of the Company''s common stock at an effective ...


04.05.2017

Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase

TORONTO, ONTARIO -- (Marketwired) -- 05/01/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has consulted with the U.S. Food and Drug Administration (the "FDA") regarding the Company''s plans to return its thrombolytic biologic drug, Kinlytic® Urokinase ("Kinlytic"), to the U.S. market.Microbix believes the results of its consultation will ...


01.05.2017

FeraMAX(R) Named #1 by Canadian Physicians and Pharmacists for Second Consecutive Year

TORONTO, ONTARIO -- (Marketwired) -- 05/01/17 -- Editors note: There is one image accompanying this press release.BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) is pleased to announce that FeraMAX® has been named the #1 recommended iron supplement brand in a national survey of Canadian physicians and pharmacists for the second consecutive year.The survey was conducted by Rogers Connect™ Market Research group and the following publications within the EnsembleIQ Healthcare Group: Pharmac ...


01.05.2017

Rising Biosciences, Inc. Launches Corporate Website, Announces Executive Research Team

NEW YORK, NY -- (Marketwired) -- 04/27/17 -- Rising India Inc. (OTC: RSII) is pleased to announce that Rising Biosciences, Inc., The Company''s recently finalized merger entity, has officially launched its corporate website, detailing its mission statement, corporate objectives and newly appointed research executives.Rising Biosciences, Inc. is a research & development company focusing on oral and topical cannabis and non-cannabis based pharmaceuticals with strict standards set f ...


27.04.2017

Pressure BioSciences, Inc. Appoints Joseph L. Damasio Jr. as Vice President of Finance and Chief Financial Officer

SOUTH EASTON, MA -- (Marketwired) -- 04/17/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Joseph L. Damasio Jr. joined the Company as its Vice President of Finance and Chief Financial Officer ("CFO") on April 10, 2017.Mr. Damasio has over ...


17.04.2017

ReproCELL and Fox Chase Cancer Center Form Strategic Alliance to Accelerate Biomarker and Genetic Discovery

BELTSVILLE, MD and PHILADELPHIA, PA -- (Marketwired) -- 04/13/17 -- ReproCELL and Fox Chase Cancer Center today announced a strategic alliance aimed at accelerating oncology discovery and translational studies. Through this alliance, ReproCELL will augment its Global Repository of biospecimens with samples from the Fox Chase Cancer Center, ensuring that researchers have access to the widest array of clinical-grade biospecimens."ReproCELL''s alliance with Fox Chase ensures that th ...


13.04.2017

Akers Biosciences Announces a $2 Million Private Placement

THOROFARE, NJ -- (Marketwired) -- 03/30/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces a private placement to raise approximately $2 million. Akers Bio will use the proceeds from the transaction as growth capital and for general corporate purposes.Akers Bio will issue 1,448,400 shares at a price of $1.40 per share, resulting in gross proceeds to the Company of $2,027,7 ...


30.03.2017

Algae Dynamics Corp Revised Business Strategy to Include Product Development Using Other Botanicals Such as Cannabis and Hemp

TORONTO, ON -- (Marketwired) -- 03/30/17 -- ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company" or "ADC"), a development stage company previously focused solely on commercialization of its proprietary BiloSilo™ system for the cultivation of highly-pure algae biomass, today announced a formal re-alignment of its business focus and strategy.The Company had previously announced, in December 2016, that it was considering ways to capitalize on synergies between its focus on algae c ...


30.03.2017

Rising India Inc. Executes Definitive Merger Agreement with Rising BioSciences, Inc.

NEW YORK, NY -- (Marketwired) -- 03/30/17 -- Rising India Inc. (OTC: RSII) announces today that it has executed the definitive merger agreement with Rising BioSciences, Inc. Appointments of new management and directors, as well as additional details on company objectives and plans will be forthcoming in future announcements.Rising BioSciences, Inc. is a research and development company focusing on oral and topical cannabis based pharmaceuticals with strict standards set forward by the pharmaceu ...


30.03.2017

Prolacta Bioscience(R) Names New Nutrition Advisory Committee Members and Expands Resources for NICU Dietitians and Clinicians

DUARTE, CA -- (Marketwired) -- 03/30/17 -- , the pioneer in human milk-based neonatal nutritional products for premature infants, today announced two new members of its Nutrition Advisory Committee (NAC): Keli Hawthorne, MS, RD, LD of Austin, Texas, and Carrie L. Petras, RD of Louisville, Ky.The NAC includes registered dietitians and board-certified specialists in pediatric nutrition, breast feeding medicine and human milk nutrition. Their goal is to provide neonatal intensive care units (NICUs ...


30.03.2017

Microbix Announces Annual Meeting Voting Results

TORONTO, ONTARIO -- (Marketwired) -- 03/30/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the Annual Meeting of Shareholders which was held on March 29, 2017, at which 37.07% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be ...


30.03.2017

Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016

THOROFARE, NJ -- (Marketwired) -- 03/30/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces preliminary unaudited earnings highlights for the fiscal year ended December 31, 2016.The Company will apply for a 15-day extension to file the Form 10-K containing its 2016 earnings so as to allow additional time for the Company and its auditors to incorporate data from certain subs ...


30.03.2017

Cytek Biosciences Poised to Accelerate Flow Cytometry Adoption

FREMONT, CA -- (Marketwired) -- 03/28/17 -- Early detection and diagnosis can greatly increase the chances of successful treatment of diseases. Flow cytometry puts time on the side of researchers and clinicians by giving them the ability to quickly analyze multiple characteristics of single cells simultaneously. Life science researchers know this, yet adoption of this technology has lagged. , a leading manufacturer and supplier of flow cytometry products and services, is charting a course to sh ...


28.03.2017

Pressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities

SOUTH EASTON, MA -- (Marketwired) -- 03/23/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that it has significantly bolstered its marketing and sales capabilities by contracting with well-known and highly regarded EKG Sales Associates, and by hiring two of ...


23.03.2017

Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 03/22/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2016, provided a business update, and offered limited guidance for FY2017.Products and services revenue was $365,262 in the fourth quarter of 2016 compared to $235,600 in the same quarter of 2015, a 55% increase. Sales of consumables were $50,054 for the fourth quarter en ...


22.03.2017

Long Range Genomic Sequencing Article Reveals DNA Fragment Generation Tip

BitesizeBio.com has published a new article entitled "Extract HMW DNA for Long-Range Genomic Analysis with the New SageHLS Platform", which sheds light on the most important aspects of extracting high molecular weight DNA for sequencing. Bitesize Bio targets those working in Life Sciences and those interested in developments in the field. The full article can be read on the [BitesizeBio website](http://bitesizebio.com/product_article/extract-hmw-dna-long-range-genomic-analysis-new-sage ...


22.03.2017

NEMUS Bioscience and the University of Mississippi Announce Significant Anti-MRSA Synergy Data Utilizing Proprietary Cannabinoid-Based Anti-Infective Platforms

COSTA MESA, CA -- (Marketwired) -- 03/22/17 -- NEMUS Bioscience, Inc. (OTCQB: NMUS) and the company''s discovery and research partner, the University of Mississippi (UM), today announced that bactericidal synergy was achieved against multiple species of methicillin-resistant Staphylococcus aureus (MRSA) utilizing a proprietary cannabinoid-based therapeutic platform. MRSA species tested included community acquired- (CA-MRSA), healthcare-acquired- (HA-MRSA), and mupirocin-resistant (MR- ...


22.03.2017

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2016 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 03/21/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2016 financial results and to provide a business update. Anyone interested may listen to the teleconference by telephone (live) or through a replay by telephone or on the Company''s website.The teleconference will include a Company presentation fo ...


21.03.2017

Nemus Bioscience Signs Development Agreement with Nanomerics to Advance Ocular Formulation of NB1111 for the Treatment of Glaucoma Using Proprietary Molecular Envelope Technology (MET)

COSTA MESA, CA -- (Marketwired) -- 03/20/17 -- (OTCQB: NMUS) announced that the company has signed a development agreement with Nanomerics Ltd. of the United Kingdom, to develop a topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinate (THCVHS), the prodrug of THC, which is the active component of Nemus drug candidate NB1111 being developed for the treatment of glaucoma. The aim of the agreement is to conduct initial studies assessing the preparation of clinical-grade eye drops ...


20.03.2017

Algae Dynamics Corp Announces Memorandum of Understanding With Company Licenced by Health Canada to Test, Extract, Purify, Import/Export and Sell Cannabis Oil

TORONTO, ON -- (Marketwired) -- 03/16/17 -- ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company" or "ADC"), a development stage company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced a memorandum of understanding with Avanti Rx Analytics Inc. ("ARA") to collaborate on a range of topics as outlined below. ARA is uniquely positioned to test, extract, develop, produce and supply cannabinoids tha ...


16.03.2017

Cytek Biosciences Introduces New Compact Flow Cytometry System

FREMONT, CA -- (Marketwired) -- 03/15/17 -- , a leading manufacturer and supplier of flow cytometry products and services, has launched its flow cytometry system. A compact, powerful, easy-to-use cell analyzer that offers the performance capabilities typically only found in instruments that come with a much higher price tag, the DxP Athena makes the benefits of flow cytometry more readily available to a larger number of researchers.Based on Cytek''s proven DxP technology, the DxP Ath ...


15.03.2017

BioSyent Releases Results for Fourth Quarter and Full Year 2016

TORONTO, ONTARIO -- (Marketwired) -- 03/15/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2016. Key highlights include:"Q4 2016 was a record quarter for BioSyent''s pharmaceutical business" commented Rene Goehrum, President and CEO of BioSyent. "Q4 2016 sales exceeded $4.9 million and represented a 30% increase over Q4 2015 pharmaceutical sales. With this ...


15.03.2017

Rising India Inc. Moves Forward With Final Agreement on Rising BioSciences Merger

NEW YORK, NY -- (Marketwired) -- 03/06/17 -- Rising India Inc. (OTC: RSII) is pleased to announce that they are preparing to execute final documents for the incoming merger of Rising BioSciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry.CEO Jim DiPrima feels this will be an incredible opportunity for the company and its shareholders moving forward. DiPrima has agreed to step ...


06.03.2017

BioSyent Schedules Fourth Quarter 2016 Earnings Release for March 15, 2017

TORONTO, ONTARIO -- (Marketwired) -- 03/06/17 -- BioSyent Inc. ("BioSyent", "the Company") (TSX VENTURE: RX) will be reporting its financial results for the fourth quarter and fiscal year ended December 31, 2016 on Wednesday, March 15, 2017. A presentation on the Company''s fourth quarter 2016 results by Rene Goehrum, BioSyent President and CEO, will also be available on the Company''s website on the date of release.About BioSyent Inc.Listed on the TSX V ...


06.03.2017

NEMUS Bioscience and Catalent to Advance NB1222 into Human Dosage Formulation Development

COSTA MESA, CA -- (Marketwired) -- 03/03/17 -- NEMUS Bioscience, Inc. (OTCQB: NMUS) today announced that the company is moving forward with Catalent Pharma Solutions (Catalent) to advance development of a human-dosage suppository formulation of NB1222, the proprietary prodrug of tetrahydrocannabinol (THC). NB1222, also known as the prodrug THC-valine-hemisuccinate, is being developed for the treatment and management of chemotherapy-induced nausea and vomiting (CINV). NB1222 is synthetically man ...


03.03.2017

Pressure BioSciences Receives 2017 North American Excellence Award: "Best New Instrument for Sample Preparation"

SOUTH EASTON, MA -- (Marketwired) -- 03/01/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that its Barocycler 2320EXTREME ("2320EXT") has been named the "Best New Instrument for Sample Preparation 2017" by Corporate America News (" ...


01.03.2017

Rising India Inc. Highlights Shareholder Conference Call Regarding Cannabis Pharmaceutical Research and Development Merger

NEW YORK, NY -- (Marketwired) -- 02/27/17 -- Rising India Inc. (OTC: RSII) has received several requests from shareholders for a recap to the Company''s Shareholder Conference call which featured detailed information about the incoming merger company, Rising Biosciences, Inc.Rising BioSciences, Inc. will be a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Aside from cancer trea ...


27.02.2017

ALGAE DYNAMICS CORP Announces Research Agreement With University of Waterloo to Investigate Use of Cannabis Oil in the Context of Cancer

TORONTO, ON -- (Marketwired) -- 02/24/17 -- ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo® cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a research agreement with the University of Waterloo to perform fundamental research on cannabis oil and its constituents in the context of the development and treatment ...


24.02.2017

Prolacta Bioscience(R) to Present at the Cowen and Company 37th Annual Health Care Conference on March 7th, 2017

DUARTE, CA -- (Marketwired) -- 02/22/17 -- Prolacta Bioscience® -- the nation''s leading provider of human milk-based neonatal nutritional products, announced today that it will present at the Cowen and Company 37th Annual Health Care Conference in Boston, MA. Scott Elster, Prolacta''s President and Chief Executive Officer, is scheduled to present on Tuesday, March 7, 2017 at 2:30 PM EST.When used as part of an exclusive human milk diet (EHMD)(1), Prolacta Bioscience'&# ...


22.02.2017

Prolacta Bioscience(R) to Present at the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017

DUARTE, CA -- (Marketwired) -- 02/17/17 -- Prolacta Bioscience® -- the nation''s leading provider of human milk-based neonatal nutritional products, announced today that it will present at the 2017 RBC Capital Markets Healthcare Conference in New York, NY. Scott Elster, Prolacta''s President and Chief Executive Officer, is scheduled to present on Wednesday, February 22, 2017 at 11:20 AM EST.When used as part of an exclusive human milk diet (EHMD)(1), Prolacta Bioscience' ...


17.02.2017

Prolacta Bioscience(R) Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect

DUARTE, CA -- (Marketwired) -- 02/16/17 -- Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a specially fortified exclusive human milk diet (EHMD)(1) to improve growth in infants who have undergone surgery for a serious heart defect known as single ventricle cardiac physiology. Prolacta developed a first-of-its-kind, human milk-based fortifier to address the ...


16.02.2017

Microbix Reports Significant Revenue Growth in First Quarter

TORONTO, ONTARIO -- (Marketwired) -- 02/14/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December 31, 2016.First Quarter Financial ResultsMicrobix reported total revenue of $1,952,502 in the first quarter, an increase of 84% from $1,063,405 in the first quarter last year. Virology product revenue increased 87% to $1,886,824 in ...


14.02.2017

Clinical Utility Study Demonstrating Improved Patient Outcomes With Proove Pain Perception Published in the Peer-Reviewed Journal of Psychiatric Research

IRVINE, CA -- (Marketwired) -- 02/13/17 -- the Healthcare Decision Company™, is pleased to announce the publication of a clinical study supporting the clinical utility of Proove Pain Perception® Profile in the latest edition of the peer-reviewed In the study entitled, An observational study of the impact of genetic testing for pain perception in the clinical management of chronic non-cancer pain, researchers from the University of Southern California Keck School of Medicine in Los Angeles, Int ...


13.02.2017

Pressure BioSciences Achieves CE Marking for its Next Generation Sample Preparation Instrument, the Barocycler 2320EXTREME

SOUTH EASTON, MA -- (Marketwired) -- 02/02/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company has achieved CE Marking for the Barocycler 2320EXTREME ("2320EXT"), the Company''s recently released, next-generation PCT-based s ...


02.02.2017

To improve the world! Central Intelligence Universe Agency. CYBER BIOS, GUIDES

People are sure that good oriented special services from Russia can turn off all really bad oriented technologies everywhere. God oriented services can do it these days, every day, all good oriented services everywhere will help to do it: turn off really bad oriented technologies. But also good oriented services will help to turn on good oriented technologies, to solve casual problems, to improve the world, to do good relations, to develop all good projects, to develop good oriented technologies ...


30.01.2017

Pressure BioSciences, Inc. to Present at RedChip''s Global Online Growth Conference

SOUTH EASTON, MA -- (Marketwired) -- 01/24/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, is scheduled to present at RedChip''s Global Online Growth Conference on Wednesday January 25, 2017, at 1 ...


24.01.2017

Surface Plasmon Resonance Techniques Article Reveals Insight For Bioscientists

BitesizeBio.com has published a new article entitled, "Examining Cell Interactions with Surface Plasmon Resonance (SPR) and Identifying Epitopes using SPR-Mass Spectrometry (MS)", which sheds light on the most important aspects of surface plasmon resonance techniques for bioscientists. BitesizeBio is used by individual scientists and companies to share their wisdom, know-how and solutions, to creating what has been called "The Missing Manual for Bioscientists". BitesizeBio.c ...


24.01.2017

To Improve Economics! Central Intelligence Universe Agency. Guides, Cyber Bios

Actual for all countries to make good economics: it is necessary take attention to do all telephone calls will come to addressees; because bad organizations (which earn when economics problems) have big network in many countries for blocking advertising calls to many companies: different percent (10 to 100) for different companies, but almost for every company (bad structures use it to change economic, social activities, but also to control mass media, because advertisers don''t pay mu ...


19.01.2017

Akers Biosciences Announces Closing of Public Offering

THOROFARE, NJ -- (Marketwired) -- 01/13/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, today announces the closing of its previously announced underwritten public offering of 1,667,000 shares of common stock at a public offering price of $1.20 per share together with the issuance of 833,500 five-year warrants to purchase common stock with an exercise price of $1.50. In addition, t ...


13.01.2017

Microbix Appoints Meridian Life Science as Distributor in Asia Pacific

TORONTO, ONTARIO -- (Marketwired) -- 01/12/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix"), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the "Agreement") with Meridian Life Science, Inc. ("Meridian") a wholly owned company of Meridian Bioscience, Inc. (NASDAQ: VIVO) a fully integrated global diagnostic and life science company.Under the terms of the Agreement, Meridian will receive exclusive di ...


12.01.2017

Pressure BioSciences, Inc. to Present at the 2017 Biotech Showcase

SOUTH EASTON, MA -- (Marketwired) -- 01/10/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 9th Annual Biotech Showcase at 5pm PST on Tuesday, January 10, 2017. The B ...


10.01.2017

Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants

THOROFARE, NJ -- (Marketwired) -- 01/09/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, today announces the entry into an agreement relating to the sale of 1,667,000 shares of common stock at a public offering price of $1.20 per share together with the issuance of 833,500 five-year warrants to purchase common stock with an exercise price of $1.50. The gross proceeds from the offe ...


10.01.2017

Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth

TORONTO, ONTARIO -- (Marketwired) -- 12/23/16 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for the three months and year ended September 30, 2016, and provided an update on its operations.Financial Highlights - Fiscal 2016 vs. Fiscal 2015Full Year Financial ResultsMicrobix reported total revenue of $9,517,137 in fiscal 2016 ("F2016"), an increase of 7% f ...


23.12.2016

Akers Biosciences Signs 3-year Agreement with GNYHA Services for Heparin PF4 Rapid Test

THOROFARE, NJ -- (Marketwired) -- 12/22/16 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, reported on December 19, 2016 that the Company has signed a three-year agreement with the Greater New York Hospital Association (GNYHA) to introduce the Company''s flagship rapid tests for heparin-induced thrombocytopenia across GNYHA''s network of over 300 member hospitals ...


22.12.2016



All members: 9 408
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 64


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.